Global Age-Related Macular Degeneration (AMD) AI Screening System Supply, Demand and Key Producers, 2024-2030

Page: 121

Published Date: 22 Apr 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Age-related macular degeneration (AMD) represents one of leading cause of visual impairment in developed countries and a major target for AI-based approaches. The analysis of AMD data is mainly based on optical coherence tomography(OCT) images; thus, image segmentation is a fundamental step for accurately recognizing retinal structures. Many unsupervised AI-based segmentation algorithms have been developed, providing very high performance in detecting   retinal features. These algorithms are useful not only for assessing the   integrity of retinal structures, but also for localizing and quantifying   retinal fluids during follow-up.

The global Age-Related Macular Degeneration (AMD) AI Screening System market size is expected to reach $ 2985 million by 2030, rising at a market growth of 79.9% CAGR during the forecast period (2024-2030).

The age-related macular degeneration (AMD) market trends are shaping the growth of the market. For instance rise in the adoption of age-related macular degeneration drugs (AMD) among the geriatric population suffering from age-related macular degeneration (AMD) drives the growth of the age-related macular degeneration (AMD) market size. For instance, according to the 2022 factsheet of World Health Organization, by 2030, 1 in 6 people in the world is projected to be aged 60 years or over, indicating a potential increase in the age-related macular degeneration (AMD) market size.

This report studies the global Age-Related Macular Degeneration (AMD) AI Screening System demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Age-Related Macular Degeneration (AMD) AI Screening System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Age-Related Macular Degeneration (AMD) AI Screening System that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Age-Related Macular Degeneration (AMD) AI Screening System total market, 2019-2030, (USD Million)
Global Age-Related Macular Degeneration (AMD) AI Screening System total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Age-Related Macular Degeneration (AMD) AI Screening System total market, key domestic companies, and share, (USD Million)
Global Age-Related Macular Degeneration (AMD) AI Screening System revenue by player, revenue and market share 2019-2024, (USD Million)
Global Age-Related Macular Degeneration (AMD) AI Screening System total market by Type, CAGR, 2019-2030, (USD Million)
Global Age-Related Macular Degeneration (AMD) AI Screening System total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Age-Related Macular Degeneration (AMD) AI Screening System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Age-Related Macular Degeneration (AMD) AI Screening System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Age-Related Macular Degeneration (AMD) AI Screening System Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Age-Related Macular Degeneration (AMD) AI Screening System Market, Segmentation by Type
    Hardware
    Software

Global Age-Related Macular Degeneration (AMD) AI Screening System Market, Segmentation by Application:
    Medical Institutions
    Great Health Scene

Companies Profiled:
    Airdoc Technology
    Digital Diagnostics
    Eyenuk
    RetinaLyze System
    Optomed
    Sibionics Technology
    Aeye Health
    VUNO
    Medimaging Integrated Solution
    EyRIS (SELENA+)
    Vistel
    RETINA-AI Health
    Acer Medical

Key Questions Answered
1. How big is the global Age-Related Macular Degeneration (AMD) AI Screening System market?
2. What is the demand of the global Age-Related Macular Degeneration (AMD) AI Screening System market?
3. What is the year over year growth of the global Age-Related Macular Degeneration (AMD) AI Screening System market?
4. What is the total value of the global Age-Related Macular Degeneration (AMD) AI Screening System market?
5. Who are the Major Players in the global Age-Related Macular Degeneration (AMD) AI Screening System market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Age-Related Macular Degeneration (AMD) AI Screening System Introduction
    1.2 World Age-Related Macular Degeneration (AMD) AI Screening System Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Age-Related Macular Degeneration (AMD) AI Screening System Total Market by Region (by Headquarter Location)
        1.3.1 World Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030)
        1.3.3 China Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030)
        1.3.4 Europe Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030)
        1.3.5 Japan Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030)
        1.3.6 South Korea Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030)
        1.3.7 ASEAN Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030)
        1.3.8 India Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030)
    2.2 World Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Region
        2.2.1 World Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Region (2019-2024)
        2.2.2 World Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Forecast by Region (2025-2030)
    2.3 United States Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030)
    2.4 China Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030)
    2.5 Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030)
    2.6 Japan Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030)
    2.7 South Korea Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030)
    2.8 ASEAN Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030)
    2.9 India Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030)

3 World Age-Related Macular Degeneration (AMD) AI Screening System Companies Competitive Analysis
    3.1 World Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Age-Related Macular Degeneration (AMD) AI Screening System in 2023
        3.2.3 Global Concentration Ratios (CR8) for Age-Related Macular Degeneration (AMD) AI Screening System in 2023
    3.3 Age-Related Macular Degeneration (AMD) AI Screening System Company Evaluation Quadrant
    3.4 Age-Related Macular Degeneration (AMD) AI Screening System Market: Overall Company Footprint Analysis
        3.4.1 Age-Related Macular Degeneration (AMD) AI Screening System Market: Region Footprint
        3.4.2 Age-Related Macular Degeneration (AMD) AI Screening System Market: Company Product Type Footprint
        3.4.3 Age-Related Macular Degeneration (AMD) AI Screening System Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Age-Related Macular Degeneration (AMD) AI Screening System Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Age-Related Macular Degeneration (AMD) AI Screening System Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Comparison
        4.2.1 United States VS China: Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Age-Related Macular Degeneration (AMD) AI Screening System Companies and Market Share, 2019-2024
        4.3.1 United States Based Age-Related Macular Degeneration (AMD) AI Screening System Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Age-Related Macular Degeneration (AMD) AI Screening System Revenue, (2019-2024)
    4.4 China Based Companies Age-Related Macular Degeneration (AMD) AI Screening System Revenue and Market Share, 2019-2024
        4.4.1 China Based Age-Related Macular Degeneration (AMD) AI Screening System Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Age-Related Macular Degeneration (AMD) AI Screening System Revenue, (2019-2024)
    4.5 Rest of World Based Age-Related Macular Degeneration (AMD) AI Screening System Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Age-Related Macular Degeneration (AMD) AI Screening System Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Age-Related Macular Degeneration (AMD) AI Screening System Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Hardware
        5.2.2 Software
    5.3 Market Segment by Type
        5.3.1 World Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024)
        5.3.2 World Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2025-2030)
        5.3.3 World Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Age-Related Macular Degeneration (AMD) AI Screening System Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Medical Institutions
        6.2.2 Great Health Scene
    6.3 Market Segment by Application
        6.3.1 World Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024)
        6.3.2 World Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2025-2030)
        6.3.3 World Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Airdoc Technology
        7.1.1 Airdoc Technology Details
        7.1.2 Airdoc Technology Major Business
        7.1.3 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.1.4 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Airdoc Technology Recent Developments/Updates
        7.1.6 Airdoc Technology Competitive Strengths & Weaknesses
    7.2 Digital Diagnostics
        7.2.1 Digital Diagnostics Details
        7.2.2 Digital Diagnostics Major Business
        7.2.3 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.2.4 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Digital Diagnostics Recent Developments/Updates
        7.2.6 Digital Diagnostics Competitive Strengths & Weaknesses
    7.3 Eyenuk
        7.3.1 Eyenuk Details
        7.3.2 Eyenuk Major Business
        7.3.3 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.3.4 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Eyenuk Recent Developments/Updates
        7.3.6 Eyenuk Competitive Strengths & Weaknesses
    7.4 RetinaLyze System
        7.4.1 RetinaLyze System Details
        7.4.2 RetinaLyze System Major Business
        7.4.3 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.4.4 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 RetinaLyze System Recent Developments/Updates
        7.4.6 RetinaLyze System Competitive Strengths & Weaknesses
    7.5 Optomed
        7.5.1 Optomed Details
        7.5.2 Optomed Major Business
        7.5.3 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.5.4 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Optomed Recent Developments/Updates
        7.5.6 Optomed Competitive Strengths & Weaknesses
    7.6 Sibionics Technology
        7.6.1 Sibionics Technology Details
        7.6.2 Sibionics Technology Major Business
        7.6.3 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.6.4 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Sibionics Technology Recent Developments/Updates
        7.6.6 Sibionics Technology Competitive Strengths & Weaknesses
    7.7 Aeye Health
        7.7.1 Aeye Health Details
        7.7.2 Aeye Health Major Business
        7.7.3 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.7.4 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Aeye Health Recent Developments/Updates
        7.7.6 Aeye Health Competitive Strengths & Weaknesses
    7.8 VUNO
        7.8.1 VUNO Details
        7.8.2 VUNO Major Business
        7.8.3 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.8.4 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 VUNO Recent Developments/Updates
        7.8.6 VUNO Competitive Strengths & Weaknesses
    7.9 Medimaging Integrated Solution
        7.9.1 Medimaging Integrated Solution Details
        7.9.2 Medimaging Integrated Solution Major Business
        7.9.3 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.9.4 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Medimaging Integrated Solution Recent Developments/Updates
        7.9.6 Medimaging Integrated Solution Competitive Strengths & Weaknesses
    7.10 EyRIS (SELENA+)
        7.10.1 EyRIS (SELENA+) Details
        7.10.2 EyRIS (SELENA+) Major Business
        7.10.3 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.10.4 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 EyRIS (SELENA+) Recent Developments/Updates
        7.10.6 EyRIS (SELENA+) Competitive Strengths & Weaknesses
    7.11 Vistel
        7.11.1 Vistel Details
        7.11.2 Vistel Major Business
        7.11.3 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.11.4 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Vistel Recent Developments/Updates
        7.11.6 Vistel Competitive Strengths & Weaknesses
    7.12 RETINA-AI Health
        7.12.1 RETINA-AI Health Details
        7.12.2 RETINA-AI Health Major Business
        7.12.3 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.12.4 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 RETINA-AI Health Recent Developments/Updates
        7.12.6 RETINA-AI Health Competitive Strengths & Weaknesses
    7.13 Acer Medical
        7.13.1 Acer Medical Details
        7.13.2 Acer Medical Major Business
        7.13.3 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
        7.13.4 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Acer Medical Recent Developments/Updates
        7.13.6 Acer Medical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Age-Related Macular Degeneration (AMD) AI Screening System Industry Chain
    8.2 Age-Related Macular Degeneration (AMD) AI Screening System Upstream Analysis
    8.3 Age-Related Macular Degeneration (AMD) AI Screening System Midstream Analysis
    8.4 Age-Related Macular Degeneration (AMD) AI Screening System Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Age-Related Macular Degeneration (AMD) AI Screening System Players in 2023
 Table 12. World Age-Related Macular Degeneration (AMD) AI Screening System Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Age-Related Macular Degeneration (AMD) AI Screening System Company Evaluation Quadrant
 Table 14. Head Office of Key Age-Related Macular Degeneration (AMD) AI Screening System Players
 Table 15. Age-Related Macular Degeneration (AMD) AI Screening System Market: Company Product Type Footprint
 Table 16. Age-Related Macular Degeneration (AMD) AI Screening System Market: Company Product Application Footprint
 Table 17. Age-Related Macular Degeneration (AMD) AI Screening System Mergers & Acquisitions Activity
 Table 18. United States VS China Age-Related Macular Degeneration (AMD) AI Screening System Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Age-Related Macular Degeneration (AMD) AI Screening System Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Age-Related Macular Degeneration (AMD) AI Screening System Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share (2019-2024)
 Table 23. China Based Age-Related Macular Degeneration (AMD) AI Screening System Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Age-Related Macular Degeneration (AMD) AI Screening System Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Age-Related Macular Degeneration (AMD) AI Screening System Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share (2019-2024)
 Table 29. World Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Age-Related Macular Degeneration (AMD) AI Screening System Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2025-2030) & (USD Million)
 Table 35. Airdoc Technology Basic Information, Manufacturing Base and Competitors
 Table 36. Airdoc Technology Major Business
 Table 37. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 38. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Airdoc Technology Recent Developments/Updates
 Table 40. Airdoc Technology Competitive Strengths & Weaknesses
 Table 41. Digital Diagnostics Basic Information, Manufacturing Base and Competitors
 Table 42. Digital Diagnostics Major Business
 Table 43. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 44. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Digital Diagnostics Recent Developments/Updates
 Table 46. Digital Diagnostics Competitive Strengths & Weaknesses
 Table 47. Eyenuk Basic Information, Manufacturing Base and Competitors
 Table 48. Eyenuk Major Business
 Table 49. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 50. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Eyenuk Recent Developments/Updates
 Table 52. Eyenuk Competitive Strengths & Weaknesses
 Table 53. RetinaLyze System Basic Information, Manufacturing Base and Competitors
 Table 54. RetinaLyze System Major Business
 Table 55. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 56. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. RetinaLyze System Recent Developments/Updates
 Table 58. RetinaLyze System Competitive Strengths & Weaknesses
 Table 59. Optomed Basic Information, Manufacturing Base and Competitors
 Table 60. Optomed Major Business
 Table 61. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 62. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Optomed Recent Developments/Updates
 Table 64. Optomed Competitive Strengths & Weaknesses
 Table 65. Sibionics Technology Basic Information, Manufacturing Base and Competitors
 Table 66. Sibionics Technology Major Business
 Table 67. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 68. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Sibionics Technology Recent Developments/Updates
 Table 70. Sibionics Technology Competitive Strengths & Weaknesses
 Table 71. Aeye Health Basic Information, Manufacturing Base and Competitors
 Table 72. Aeye Health Major Business
 Table 73. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 74. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Aeye Health Recent Developments/Updates
 Table 76. Aeye Health Competitive Strengths & Weaknesses
 Table 77. VUNO Basic Information, Manufacturing Base and Competitors
 Table 78. VUNO Major Business
 Table 79. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 80. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. VUNO Recent Developments/Updates
 Table 82. VUNO Competitive Strengths & Weaknesses
 Table 83. Medimaging Integrated Solution Basic Information, Manufacturing Base and Competitors
 Table 84. Medimaging Integrated Solution Major Business
 Table 85. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 86. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Medimaging Integrated Solution Recent Developments/Updates
 Table 88. Medimaging Integrated Solution Competitive Strengths & Weaknesses
 Table 89. EyRIS (SELENA+) Basic Information, Manufacturing Base and Competitors
 Table 90. EyRIS (SELENA+) Major Business
 Table 91. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 92. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. EyRIS (SELENA+) Recent Developments/Updates
 Table 94. EyRIS (SELENA+) Competitive Strengths & Weaknesses
 Table 95. Vistel Basic Information, Manufacturing Base and Competitors
 Table 96. Vistel Major Business
 Table 97. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 98. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Vistel Recent Developments/Updates
 Table 100. Vistel Competitive Strengths & Weaknesses
 Table 101. RETINA-AI Health Basic Information, Manufacturing Base and Competitors
 Table 102. RETINA-AI Health Major Business
 Table 103. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 104. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. RETINA-AI Health Recent Developments/Updates
 Table 106. RETINA-AI Health Competitive Strengths & Weaknesses
 Table 107. Acer Medical Basic Information, Manufacturing Base and Competitors
 Table 108. Acer Medical Major Business
 Table 109. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product and Services
 Table 110. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. Acer Medical Recent Developments/Updates
 Table 112. Acer Medical Competitive Strengths & Weaknesses
 Table 113. Global Key Players of Age-Related Macular Degeneration (AMD) AI Screening System Upstream (Raw Materials)
 Table 114. Global Age-Related Macular Degeneration (AMD) AI Screening System Typical Customers


List of Figures
 Figure 1. Age-Related Macular Degeneration (AMD) AI Screening System Picture
 Figure 2. World Age-Related Macular Degeneration (AMD) AI Screening System Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Age-Related Macular Degeneration (AMD) AI Screening System Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Age-Related Macular Degeneration (AMD) AI Screening System Revenue (2019-2030) & (USD Million)
 Figure 13. Age-Related Macular Degeneration (AMD) AI Screening System Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Age-Related Macular Degeneration (AMD) AI Screening System by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Age-Related Macular Degeneration (AMD) AI Screening System Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Age-Related Macular Degeneration (AMD) AI Screening System Markets in 2023
 Figure 27. United States VS China: Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type in 2023
 Figure 31. Hardware
 Figure 32. Software
 Figure 33. World Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2030)
 Figure 34. World Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 35. World Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application in 2023
 Figure 36. Medical Institutions
 Figure 37. Great Health Scene
 Figure 38. World Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2030)
 Figure 39. Age-Related Macular Degeneration (AMD) AI Screening System Industrial Chain
 Figure 40. Methodology
 Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical

Related Reports

Global Age-Related Macular Degeneration (AMD) AI Screening System Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Age-Related Macular Degeneration (AMD) AI Screening System Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 22 Apr 2024

date Service & Software

Age-related macular degeneration (AMD) represents one of leading cause of visual impairment in developed countries and a major target for AI-based approaches. The analysis of AMD data is mainly based on optical coherence tomography(OCT) images; thus, image segmentation is a fundamental step for accurately recognizing retinal structures. Many unsupervised AI-based segmentation algorithms have been developed, providing very high performance in detecting retinal features. These algorithms are useful not only for assessing the integrity of retinal structures, but also for localizing and quantifying retinal fluids during follow-up.

Product Tags

soil fertility

Image High Dynamic

Building Energy Modeling

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>